Open AccessBupropion-induced acute dystonia in a patient with bulimia nervosa: A case report
Author(s) -
Parvane Rashidpour,
Zahra Poursharif,
Mina Aghaei,
Elham Farzannejad
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_1173_20
Subject(s) - bupropion , medicine , nausea , dystonia , antidepressant , akathisia , constipation , anxiety , adverse effect , bulimia nervosa , anxiolytic , anesthesia , psychiatry , eating disorders , smoking cessation , antipsychotic , pathology , schizophrenia (object oriented programming)
Bupropion is taken as an antidepressant for treatment of major depressive disorders, treatment of sexual side effects of selective serotonin reuptake inhibitors, and as a smoking cessation aid, however, it may result in adverse effects such as nausea, dry mouth, headache, insomnia, dizziness, anxiety, tremor, and constipation. We investigate the case of a 34-year-old woman with bulimia nervosa where acute dystonia was induced by bupropion in 8 months. Following this diagnosis and after normal tests and MRI results, the patient was advised to discontinue bupropion intake. In the follow-up done 2 weeks later, 3 months later, and 6 months later, no signs of acute dystonia was observed. A physician who administers dopamine blocking agents must be aware of the prevalence of and the risk factors for acute dystonia and also the way of prevention and treatment.